Ciencias Químicas
Facultat
![Foto de Ciencias Químicas](/img/uploaded/F9DD5DC76A96F8B726E155338CC9E85E.jpg)
![Foto de Charité](/img/noimage_org.png)
Charité
Berlín, AlemaniaPublicacions en col·laboració amb investigadors/es de Charité (34)
2024
-
Multivalent, calcium-independent binding of surfactant protein A and D to sulfated glycosaminoglycans of the alveolar epithelial glycocalyx
American journal of physiology. Lung cellular and molecular physiology, Vol. 326, Núm. 5, pp. L524-L538
2023
-
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1169-1203
-
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Nature Reviews Drug Discovery, Vol. 22, Núm. 9, pp. 743-767
2022
-
Cigarette smoke augments CSF3 expression in neutrophils to compromise alveolar-capillary barrier function during influenza infection
European Respiratory Journal, Vol. 60, Núm. 2
-
EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 1, pp. 17-38
2021
-
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
Clinical and Translational Allergy, Vol. 11, Núm. 4
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 3, pp. 648-676
-
Cysteine and iron accelerate the formation of ribose-5-phosphate, providing insights into the evolutionary origins of the metabolic network structure
PLoS Biology, Vol. 19, Núm. 12
-
EAACI Biologicals Guidelines—dupilumab for children and adults with moderate-to-severe atopic dermatitis
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 4, pp. 988-1009
-
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 45-58
-
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 59-70
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
What is the contribution of IgE to nasal polyposis?
Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 6, pp. 1997-2008
2020
-
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 10, pp. 2503-2541
-
Air space distension precedes spontaneous fibrotic remodeling and impaired cholesterol metabolism in the absence of surfactant protein C
American Journal of Respiratory Cell and Molecular Biology, Vol. 62, Núm. 4, pp. 466-478
-
Allergic rhinitis
Nature Reviews Disease Primers, Vol. 6, Núm. 1
-
Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie
Allergologie, Vol. 43, Núm. 7, pp. 255-271
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 11, pp. 2764-2774
-
In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition
Scientific Reports, Vol. 10, Núm. 1
-
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan—An EAACI position paper
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 9, pp. 2161-2169